Diaccurate est soutenue par Bpifrance pour son Programme DIACC2020 portant sur le développement de nouveaux composés cytotoxiques conjugués à des anticorps thérapeutiques (ADCs)
January 05, 2023 02:00 ET
|
DIACCURATE
La plateforme DIACC2020 ambitionne de mettre au point une nouvelle génération de composés cytotoxiques pouvant être conjugués à des anticorps thérapeutiquesElle s’appuie sur les propriétés uniques du...
ITM to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023 10:30 ET
|
ITM Isotope Technologies Munich SE
Garching / Munich, January 03, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that CEO Steffen Schuster and CFO Dr. Klaus Maleck will...
Agile Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 05, 2022 08:03 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and Chief Executive Officer Al Altomari will...
Agile Therapeutics to Present at the Biotech Showcase and H.C. Wainwright BioConnect Virtual Conferences
January 05, 2022 08:01 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced Chairman and Chief Executive Officer Al Altomari will...
Idera Pharmaceuticals to Present at Upcoming Conferences
January 11, 2021 06:02 ET
|
Idera Pharmaceuticals, Inc.
EXTON, Pa., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today announced that it will provide a company outlook for 2021 at upcoming conferences. “2021 represents a...
ROSEN, A RESPECTED LAW FIRM, Reminds JPMorgan Chase & Co. Investors of Important December 23 Deadline in Securities Class Action First Filed by the Firm; Encourages Investors with Losses in Excess of $100K to Contact Firm – JPM
November 20, 2020 18:15 ET
|
The Rosen Law Firm PA
NEW YORK, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of JPMorgan Chase & Co. (NYSE: JPM) between February 23, 2016...
ROSEN, LEADING INVESTOR COUNSEL, Files First Securities Class Action Lawsuit Against JPMorgan Chase & Co.; Encourages Investors with Losses Exceeding $100K to Contact the Firm – JPM
October 26, 2020 18:00 ET
|
The Rosen Law Firm PA
NEW YORK, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of JPMorgan...
Digital Asset Monetary Network Provides Update on Current Endeavors
April 23, 2019 08:43 ET
|
Digital Asset Monetary Network, Inc.
NEW YORK, April 23, 2019 (GLOBE NEWSWIRE) -- Digital Asset Monetary Network, Inc. or “DigitalAMN” (OTCMKTS: DATI), a Public Accelerator-Incubator (“PAI”), announced today, that DigitalAMN has a...
Sharecare to present at J.P. Morgan Healthcare Conference for sixth consecutive year
January 02, 2019 08:00 ET
|
Sharecare
ATLANTA, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Sharecare, the digital health company helping people manage all their health in one place, today announced it will present at the 37th annual J.P. Morgan...
Peregrine Pharmaceuticals to Present at Biotech Showcase 2018
January 02, 2018 08:05 ET
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company committed to improving patient lives by manufacturing and delivering high...